DeMichele, Angela
Robert, Nicholas
Chen, Connie
Kim, Sindy
Zhang, Zhe
Lu, Dongrui Ray
Aguilar, Kathleen M.
Wang, Yunfei
Li, Benjamin
Schneeweiss, Sebastian
Rassen, Jeremy A.
Gaffney, Michael
McRoy, Lynn
Article History
Accepted: 27 May 2023
First Online: 10 July 2023
Declarations
:
: This study was sponsored by Pfizer Inc.
: Angela DeMichele reports institutional research support from Calithera, Genentech, Novartis, Pfizer, and Inivata; research writing support from Pfizer; and that her spouse serves on a Pfizer Data and Safety Monitoring Board for a drug unrelated to cancer. Nicholas Robert, Kathleen M. Aguilar, and Yunfei Wang are employees of and hold stock/stock options in Ontada, a brand within McKesson, and have performed contracted research for Pfizer. Connie Chen, Sindy Kim, Zhe Zhang, Dongrui Ray Lu, Benjamin Li, Michael Gaffney, and Lynn McRoy are employees of and hold stock/stock options in Pfizer. Sebastian Schneeweiss reports employment with Brigham and Women’s Hospital; participating in investigator-initiated grants to his institution from Boehringer Ingelheim, Takeda, and UCB Pharma on topics unrelated to this study; consulting fees and equity from Aetion; and an advisory role for Temedica GmbH. Jeremy A. Rassen has an ownership interest in and is an employee of Aetion.
: The study was submitted to the US Oncology Institutional Review Board, but a full evaluation was deemed not required as it was a secondary data collection study.
: This study was granted an exception and waiver of informed consent from the US Oncology Institutional Review Board, and a deidentified data set was used for analysis.
: Not applicable.
: Upon request, and subject to review, Pfizer will provide the data that support the findings of this study. Subject to certain criteria, conditions, and exceptions, Pfizer may also provide access to the related individual de-identified participant data. See ExternalRef removed for more information.
: Not applicable.
: Study conceptualization: AD, NR, CC, KMA, SS, JAR, and LM Methodology (design or development): AD, NR, CC, SK, ZZ, DRL, KMA, BL, SS, JAR, MG, and LM Data analysis: CC, SK, ZZ, DRL, BL, MG, and LM Validation (verification of results/data): YW Investigation (conducting research/experiments): CC, ZZ, DRL, BL, MG, and LM Resources (provision of study materials, samples, analysis tools): NR, CC, ZZ, DRL, KMA, BL, MG, and LM Data curation (data management/organization): NR, KMA, and YW Supervision (oversight for research planning and execution): NR, CC, ZZ, DRL, KMA, BL, MG, and LM Writing (original draft preparation): AD, CC, SK, SS, JAR, and LM Writing (review and editing): all authors.